You are here
Imaging multiple sclerosis
Olfactory bulb and olfactory sulcus depths are associated with disease duration and attack frequency in multiple sclerosis patients
Nermin Tanik, Halil Ibrahim Serin, Asuman Celikbilek, Levent Ertugrul Inan, Fatma Gundogdu
Journal of the Neurological Sciences, Volume 358, Issues 1–2, 15 November 2015, Pages 304–307
Impairment of visuospatial/visuoconstructional skills in multiple sclerosis patients: the correlation with regional lesion load and subcortical atrophyNeurología, Available online 3 September 2015
Improved Detection of Cortical Gray Matter Involvement in Multiple Sclerosis with Quantitative Susceptibility MappingAcademic Radiology, Volume 22, Issue 11, November 2015, Pages 1427–1432
Interview with Daniel S. Reich: T2 flair scan after gadolinium to enhance abnormalities in the meninges overlaying the brain in patients with MSProfessor Reich described the use of a special form of MRI, the T2 flair scan, to detect leakage and inflammation...
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status
Athanasios Papathanasiou, Lambros Messinis, Petros Zampakis, Georgios Panagiotakis, Philippos Gourzis, Vasileios Georgiou, Panagiotis Papathanasopoulos
Journal of the Neurological Sciences, Volume 358, Issue 1-2, November 2015, Pages 236 - 242
The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis
Marion Simpson, Richard Macdonell
Multiple Sclerosis and Related Disorders, Volume 4, Issue 5, September 2015, Pages 430 - 436
Anthony Faivre, Audrey Rico, Wafaa Zaaraoui, Françoise Reuter, Sylviane Confort-Gouny, Maxime Guye, Jean Pelletier, Jean-Philippe Ranjeva, Bertrand Audoin
Journal of Clinical Neuroscience, Volume 22, Issue 9, September 2015, Pages 1438 - 1443
- In her speech, the award winner Dr. Airas, said that it had been very difficult to find treatments for progressive multiple sclerosis. One reason was that the pathology changes as the disease progresses.
- Microglia in MS might have two different phenotypes, according to Dr. de Fries. M1 were pro-inflammatory and neurodestructive and might also be deleterious to neuronal function; M2 were anti-inflammatory and neuro-protective.
- Professor Bates briefly summarised progress made by the recipients of the 2013 and 2014 grants.